These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25602107)

  • 1. Quality of life with treated acute promyelocytic leukaemia.
    Rahman A
    Lancet Oncol; 2014 Nov; 15(12):e533. PubMed ID: 25602107
    [No Abstract]   [Full Text] [Related]  

  • 2. [Arsenic trioxide, a new drug for the treatment of acute promyelocytic leukemia resistant to tretinoine].
    Haanen C; Vermes I
    Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1738-41. PubMed ID: 10494320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival of acute promyelocytic leukaemia patients treated with arsenic and retinoic acid.
    Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Chen SJ; Huang XJ
    Br J Haematol; 2016 Sep; 174(5):820-2. PubMed ID: 27545413
    [No Abstract]   [Full Text] [Related]  

  • 4. De-escalation of treatment for acute promyelocytic leukaemia?
    Mathews V
    Lancet Haematol; 2015 Sep; 2(9):e348-9. PubMed ID: 26685765
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo evidence of all-trans retinoic acid inducing maturation in acute promyelocytic leukaemia.
    Hamidah HN; Cheong SK; Ainoon O
    Acta Haematol; 1993; 89(1):50-1. PubMed ID: 8480488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningeal relapse in a patient with acute promyelocytic leukaemia treated with all-trans retinoic acid.
    Martino B; Vincelli I; Marino A; Comis M; Ronco F; Nobile F
    Br J Haematol; 1998 Mar; 100(3):606-7. PubMed ID: 9504652
    [No Abstract]   [Full Text] [Related]  

  • 7. How health-related quality-of-life outcomes in patients with acute promyelocytic leukemia can help physicians in decision making.
    Koehler M; Fischer T
    J Clin Oncol; 2015 Mar; 33(9):1090-1. PubMed ID: 25691667
    [No Abstract]   [Full Text] [Related]  

  • 8. TRAIL leads to apoptosis in acute promyelocytic leukaemia.
    Bradbury J
    Lancet; 2001 Jun; 357(9270):1770. PubMed ID: 11403822
    [No Abstract]   [Full Text] [Related]  

  • 9. Filgrastim combined with tretinoin in acute promyelocytic leukaemia.
    Usuki K; Ikeda Y; Kitazume K; Iwabe K; Okuyama Y; Urabe A
    Lancet; 1994 Mar; 343(8900):803-4. PubMed ID: 7510817
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxicity of tretinoin in acute promyelocytic leukaemia.
    de Lacerda JF
    Lancet; 1994 Feb; 343(8893):360-1. PubMed ID: 7905173
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxicity of tretinoin in acute promyelocytic leukaemia.
    Yokokura M; Hatake K; Komatsu N; Kajitani H; Miura Y
    Lancet; 1994 Feb; 343(8893):361-2. PubMed ID: 7905175
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxicity of tretinoin in acute promyelocytic leukaemia.
    Schmitt K; Schwarz R; Tulzer G; Krieger O; Zoubek A; Gadner H
    Lancet; 1994 Feb; 343(8893):361. PubMed ID: 7905174
    [No Abstract]   [Full Text] [Related]  

  • 13. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
    Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged complete remission in two cases of acute promyelocytic leukaemia treated with atra alone.
    Shehata N; Walker IR; Carter RC; Neame PB; Leber B
    Br J Haematol; 2002 Jun; 117(3):768. PubMed ID: 12028058
    [No Abstract]   [Full Text] [Related]  

  • 15. Central nervous system relapse in acute promyelocytic leukaemia treated with ATRA.
    Currie J; Chee YL; Culligan DJ
    Br J Haematol; 1997 Nov; 99(2):469. PubMed ID: 9375778
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute promyelocytic leukaemia, tretinoin, and granulocyte colony-stimulating factor.
    Nakajima K; Hatake K; Miyata T; Muroi K; Komatsu N; Miura Y
    Lancet; 1994 Jan; 343(8890):173-4. PubMed ID: 7506343
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful use of all-trans retinoic acid in acute promyelocytic leukaemia presenting during the second trimester of pregnancy.
    Harrison P; Chipping P; Fothergill GA
    Br J Haematol; 1994 Mar; 86(3):681-2. PubMed ID: 8043456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All trans-retinoic acid in the treatment of promyelocytic leukaemia--a case report.
    Hoe TS; Cheong SK; Hussin NH; Chum KW
    Med J Malaysia; 1992 Sep; 47(3):225-7. PubMed ID: 1491649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalcaemia caused by all-trans retinoic acid treatment of acute promyelocytic leukaemia: case report.
    Suzumiya J; Asahara F; Katakami H; Kimuran N; Hisano S; Okumura M; Ohno R
    Eur J Haematol; 1994 Aug; 53(2):126-7. PubMed ID: 8088385
    [No Abstract]   [Full Text] [Related]  

  • 20. Central nervous system relapse in acute promyelocytic leukaemia treated with all-trans retinoic acid.
    Seldon M; Enno A
    Aust N Z J Med; 1998 Aug; 28(4):462. PubMed ID: 9777115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.